Afghanistan’s Health Minister Meets India’s PharmEXCIL to Expand Cooperation in Medicines and Medical Supplies

rasooli_admin
Mon, Dec 22 2025 10:22 AM
moph

Afghanistan’s Health Minister, Mawlawi Noor Jalal Jalali, met with India’s Pharmaceuticals Export Promotion Council (PharmEXCIL) during his official visit to India.

The talks focused on boosting cooperation in medicines, medical products, and healthcare equipment, highlighting affordable and quality drug access.

H.E. Jalali called PharmEXCIL’s support crucial for strengthening Afghanistan’s healthcare system and delivering standardised services.

He added the partnership is strategically important for drug safety, quality assurance, and sustainable health services.

PharmEXCIL outlined its work in pharmaceuticals, vaccines, biologics, medical devices, diagnostics equipment, herbal medicines, contract manufacturing, and R&D.

The council, under India’s Ministry of Commerce, oversees the promotion, regulation, and export of Indian medicines and health products.

PharmEXCIL also donated around 100,000 patches to Afghanistan to support treatment of seasonal illnesses.

Latest news

Mon, Dec 22 2025 2:48 PM
Background image

A meeting was held in Kabul to improve coordination with heads of diagnostic departments at central hospitals

The meeting was organised by the Diagnostic Services Directorate of the Ministry of Public Health and took place at Indira Gandhi Children’s Hospital. It was attended by the Director. . .

Mon, Dec 22 2025 2:41 PM
Background image

Five-day medicines use workshop held in Ghor

A five-day training workshop on the rational use of drugs (RUD) has been held in Afghanistan’s central province of Ghor. The event was organised by the provincial public health. . .

Mon, Dec 22 2025 2:37 PM
Background image

Faryab Health Officials Inspect Private Drug Suppliers

Health authorities in Afghanistan’s Faryab Province inspected 59 private-sector pharmaceutical facilities over the past month, including drug wholesalers and company agencies in the. . .

BACK TO NEWS